GTHP
GUIDED THERAPEUTICS INCCompany Information
- Company Name
- GUIDED THERAPEUTICS INC
- CIK
- CIK0000924515
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GTHP: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- GTHP
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-08-29
- Last sale
- —
- Shares purchased (TTM)
- 5,304,619
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2021-06-30
- Institutional shares owned
- 1
- Shares outstanding
- 13,280
- Ownership
- 0.01%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -31.03%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Preferred Shares | - | - | - | 0 | -0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Series C One Preferred Shares | - | - | - | 0 | 0 | 0 | 0 | - | - | 0 | 0 | -1 | ||||||
| Series C Two Preferred Shares | - | - | - | 0 | 0 | 0 | 0 | - | - | 0 | 0 | 0 | ||||||
| Series D Convertible Preferred Shares | - | - | - | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series E Convertible Preferred Shares | - | - | - | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series F Convertible Preferred Shares | - | - | - | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets | ||||||||||||||||||
| Series F Two Convertible Preferred Shares | - | - | - | 0 | -0 | 0 | 0 | - | - | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Accrued Liabilities Current | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Compensation Liability Current | 0 | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Deferred Revenue Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Bank Loans And Notes Payable | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Debt Default Shortterm Debt Amount | - | - | - | - | - | - | - | 1 | 1 | - | - | - | ||||||
| Derivative Fair Value Of Derivative Liability | - | - | - | - | - | - | - | 0 | 0 | - | - | - | ||||||
| Notes Payable Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Liabilities Current | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | ||||||
| Short Term Non Bank Loans And Notes Payable | - | - | 0 | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Convertible Debt Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | ||||||
| Derivative Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 6 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Additional Paid In Capital | 149 | 149 | 146 | 145 | 144 | 144 | 143 | 142 | 141 | 141 | 141 | 141 | ||||||
| Stockholders Equity Before Treasury Stock | - | - | -0 | - | - | - | -0 | - | - | - | - | - | ||||||
| Treasury Stock Common Value | -0 | -0 | - | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -159 | -158 | -157 | -156 | -155 | -154 | -154 | -153 | -152 | -152 | -151 | -151 | ||||||
| Stockholders Equity | -6 | -5 | -6 | -6 | -5 | -5 | -5 | -5 | -5 | -4 | -4 | -4 | ||||||
| Liabilities And Stockholders Equity | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | ||||||
| Series C One Convertible Preferred Shares | - | - | - | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series C Two Convertible Preferred Shares | - | - | - | 0 | -5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series C Preferred Share | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Accounts And Notes Receivable Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Finished Goods Net Of Reserves | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Allowance For Doubtful Accounts Receivable | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Inventory Valuation Reserves | 1 | 1 | 1 | 1 | 1 | - | 1 | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGUIDED THERAPEUTICS INC (GTHP) — SEC Financial Statements & Analysis
GUIDED THERAPEUTICS INC (GTHP) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. GUIDED THERAPEUTICS INC trades on OTC as: GTHP. GUIDED THERAPEUTICS INC (GTHP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, GUIDED THERAPEUTICS INC carries a market cap of $23.17K, a P/E ratio of -0.01x, a P/B ratio of -0.00x, a P/S ratio of 0.04x, an enterprise value of $354.17K, and an EV/EBITDA multiple of -0.18x. On profitability, it posts a gross margin of 32.93%, an operating margin of -303.85%, a net margin of -567.69%, a Return on Equity (ROE) of 65.69%, and a Return on Assets (ROA) of -345.67%. Per share, it reports EPS of $-38.22, diluted EPS of $-38.22, free cash flow per share of $-15.60, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 450.85% year-over-year, net income growth of 45.22% year-over-year, and EPS growth of 18.60% year-over-year. On the balance sheet, it maintains a current ratio of 0.09x, a quick ratio of 0.00x, working capital of $-5.64M, a debt-to-equity ratio of -1.21x, a debt ratio of 5.82, an interest coverage ratio of -3.29x, free cash flow of $-1.51M (TTM), and net debt of $331.00K. Figures sourced from SEC EDGAR.
- Market Cap
- $23.17K
- P/E TTM
- -0.01x
- EPS TTM
- $-38.22
- P/B TTM
- -0.00x
- ROE TTM
- 65.69%
- ROA TTM
- -345.67%
- Debt To Equity
- -1.21x
- Free Cash Flow TTM
- $-1.51M
- Net Revenue TTM Growth 1Y
- 450.85%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GUIDED THERAPEUTICS INC in?
GUIDED THERAPEUTICS INC (GTHP) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does GTHP trade on?
GUIDED THERAPEUTICS INC (GTHP) trades on the OTC.
Where is GUIDED THERAPEUTICS INC incorporated?
GUIDED THERAPEUTICS INC is incorporated in DE.
When was GUIDED THERAPEUTICS INC (GTHP)'s most recent SEC filing?
GUIDED THERAPEUTICS INC (GTHP)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is GTHP's market cap?
GUIDED THERAPEUTICS INC (GTHP) has a market capitalization of $23.17K as of 2026-06-30.
What is GTHP's EPS (earnings per share)?
GUIDED THERAPEUTICS INC (GTHP)'s trailing twelve month EPS is $-38.22 as of 2026-06-30.
What is GTHP's ROE (return on equity)?
GUIDED THERAPEUTICS INC (GTHP)'s trailing twelve month Return on Equity (ROE) is 65.69% as of 2026-06-30.
What is GTHP's ROA (return on assets)?
GUIDED THERAPEUTICS INC (GTHP)'s trailing twelve month Return on Assets (ROA) is -345.67% as of 2026-06-30.
What is GTHP's EV/EBITDA?
GUIDED THERAPEUTICS INC (GTHP)'s trailing twelve month EV/EBITDA is -0.18x as of 2026-06-30.